Literature DB >> 795797

Problems with beaded fluorescence pattern in FTA-ABS test.

F D Pien, H Markowitz, C H McKenna, A L Schroeter.   

Abstract

The significance of false-positive FTA-ABS fluorescence in connective tissue diseases and other clinical conditions was evaluated by studying the serum from several groups of patients. In 12% of 67 patients without syphilis, serum with an antinuclear antibody (ANA) titer of 1:32 or greater gave low intensity FTA-ABS test fluorescence. In 20% of 150, patients (2.7% with a history of syphilis), serum with rheumatoid factor (RF) titers of 1:640 or greater demonstrated some reactivity. Only 1.3% of 75 donors of normal blood showed low-grade FTA-ABS fluorescence. In 385 patients with diagnostic problems, 2.1% of the serum demonstrated the beaded pattern. Patterns varied, depending on the treponemal antigen preparation and the duration of serum storage. Also, multiple specimens from the same patient produced different patterns. Furthermore, the beaded pattern could be demonstrated in patients with a history of syphilis, with other medical disorders, and in apparently normal persons.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 795797

Source DB:  PubMed          Journal:  J Am Vener Dis Assoc        ISSN: 0095-148X


  4 in total

1.  Enzyme-linked immunosorbent assay for the detection of serum antibody to outer membrane proteins of Treponema pallidum.

Authors:  J Morrison-Plummer; J F Alderete; J B Baseman
Journal:  Br J Vener Dis       Date:  1983-04

2.  Non-specific positive test results to syphilis in dermatological diseases.

Authors:  M Gibowski; E Neumann
Journal:  Br J Vener Dis       Date:  1980-02

3.  Routine Serologic Testing for Syphilis in a Community Medical Practice.

Authors:  P W Ho; F D Pein; K A Pruett
Journal:  West J Med       Date:  1980-06

4.  Influence of genital herpes on results of fluorescent treponemal antibody absorption test.

Authors:  T Chapel; C D Jeffries; W J Brown; J A Stewart
Journal:  Br J Vener Dis       Date:  1978-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.